Rare diseases
Investigational molecules
Locations
Back to France2 221 clinical trials in Lyon, France across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma
FranceStudy of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer
FranceStudy of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema
FranceStudy on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy on the Effects of Samuraciclib and Elacestrant for Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer
FranceStudy on Apalutamide and Drug Combination for Patients with Metastatic Castration-Sensitive Prostate Cancer
FranceStudy Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma
FranceStudy of Axicabtagene Ciloleucel for Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
FranceStudy on Enfortumab Vedotin and Pembrolizumab for Patients with Advanced Urothelial Cancer
FranceStudy Comparing MK-7684A with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
FranceStudy on the Long-Term Safety of Sacituzumab Govitecan for Patients with Metastatic Solid Tumors
FranceStudy on the Safety and Effectiveness of BLU-222 Alone and with Drug Combination for Patients with Advanced Solid Tumors, Including Breast and Ovarian Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for endometrial carcinoma, bladder cancer, and various solid tumors. Current research explores combination therapies with novel immunotherapy approaches.
Multiple studies are evaluating targeted therapies and immunological approaches for various tumor types.
Groundbreaking research in immune system modulation and infectious disease prevention, including studies on COVID-19 vaccines and immune response in critical conditions.
Focus on developing innovative vaccination strategies and immune system interventions.
Studies addressing long-term health conditions, with particular emphasis on kidney disease, cardiovascular health, and metabolic disorders.
Innovative approaches combining established and experimental treatments for improved patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
